Actavis to Pay $84 Million to End Medicaid Drug-Pricing Suit

Two units of Actavis Group Hf will pay $84 million to settle a lawsuit over drug pricing, Texas officials said, less than half the amount an Austin jury said the company should pay.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.